Elite already had a "run" up to $0.97/share on no news, just shear speculation and manipulation.
It has already been discussed in the past as to what another run would look like should this stock run again. I believe the new target was $1.34/share.
Having been in the market since 1998, prior to that I dabbled but not on the internet, I have seen demand for a product drive stock price.
Heck, I've seen companies with no revenue "shoot the moon". And I have seen a company's stock price go way up on a concept like the tunnel moss diode. The OTCbb company was National Scientific under Lou Ross.
Bottom line here is that word of mouth may end up driving this stock price. Lots of folks excited about treatments for Parkinson Disease.
Then again, it could be the other way, where revenues drive the share price. Nothing will surprise me. Been there done that.
One more thing comes to mind with Elite though, which a share holder would rather own, Elite or Teva. Elite will definitely give more bang for the buck in my opinion.
So, a few things could happen here...… but I tend to think Elite's stock price will react more than some think it may.
Soon we will find out, and I am not afraid to be wrong because revenue will ultimately drive the stock price in the end.
News 
Market Data 
Discover 
AI
